OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company’s first AI agent that can act autonomously on the web. But OpenAI is not Altman’s only ...
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...